Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) FCF Margin (2022 - 2025)

Historic FCF Margin for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to 901.82%.

  • Lucid Diagnostics' FCF Margin fell 336400.0% to 901.82% in Q3 2025 from the same period last year, while for Sep 2025 it was 996.01%, marking a year-over-year increase of 653400.0%. This contributed to the annual value of 1022.46% for FY2024, which is 3382500.0% up from last year.
  • Lucid Diagnostics' FCF Margin amounted to 901.82% in Q3 2025, which was down 336400.0% from 878.25% recorded in Q2 2025.
  • Lucid Diagnostics' FCF Margin's 5-year high stood at 846.28% during Q4 2024, with a 5-year trough of 9665.79% in Q3 2022.
  • Its 4-year average for FCF Margin is 2294.97%, with a median of 1220.04% in 2024.
  • As far as peak fluctuations go, Lucid Diagnostics' FCF Margin soared by 85425500bps in 2023, and later plummeted by -2572600bps in 2025.
  • Quarter analysis of 4 years shows Lucid Diagnostics' FCF Margin stood at 3801.79% in 2022, then soared by 74bps to 976.35% in 2023, then grew by 13bps to 846.28% in 2024, then dropped by -7bps to 901.82% in 2025.
  • Its FCF Margin stands at 901.82% for Q3 2025, versus 878.25% for Q2 2025 and 1520.89% for Q1 2025.